Skip to main content
Premium Trial:

Request an Annual Quote

Brian Brille, Michael Sullivan, Nicholas Nelson

Caris Life Sciences appointed Brian Brille as vice chairman, Michael Sullivan as chief commercial officer, and Nicholas Nelson as chief business officer. Brille will be responsible for corporate and business development, M&A, and capital markets. He has more than 25 years of experience as a senior financial services executive. Most recently, he was president of Asia Pacific for Bank of America Merrill Lynch. Before that, he was global head of corporate and investment banking at Bank of America. 

Before joining Caris, Sullivan was at Roche Diagnostics where he was most recently senior vice president, general manager, and business unit lifecycle leader of the company's core oncology franchise. He also held commercial leadership roles at Johnson & Johnson Ortho-Clinical Diagnostics and Abbott Laboratories' diagnostics division. 

Nelson was vice president of commercial and corporate development at Trovagene before joining Caris. He also spent 10 years at Illumina in R&D, technical service, and sales. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.